NIH-funded research R01 grant

Understanding different types of diabetes to improve prevention and treatment

Official title: Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention

Funded at Stanford University · NIH-11051066 · Data updated 2026-11-12

This study is looking at different types of diabetes and prediabetes to find better ways to treat each person based on their unique body characteristics, so if you have diabetes or prediabetes, your treatment can be more personalized and effective just for you.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$714,440
NIH project number1R01DK139472-01A1
Project IDNIH-11051066 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are diagnosed with prediabetes or early-stage type 2 diabetes.

Less likely to help

Patients with type 1 diabetes or those who do not have prediabetes or early-stage type 2 diabetes may not benefit from this research.

What this research studies

This research investigates the various physiological subtypes of diabetes and prediabetes to enhance personalized treatment approaches. By analyzing biological markers and metabolic processes, the study aims to classify individuals based on their unique physiological characteristics rather than just clinical symptoms. This could lead to more effective prevention strategies and targeted therapies tailored to each patient's specific needs. The research employs advanced multi-omics techniques to gather comprehensive data on participants' metabolic functions.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective diabetes prevention and treatment strategies for patients.

How similar studies have gone: Previous research has shown promise in using multi-omics approaches to understand diabetes heterogeneity, indicating potential for success in this novel investigation.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Mclaughlin, Tracey — Stanford University
  • Study coordinator: Mclaughlin, Tracey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.